Considerations on clinical trials of leprosy treatment: need of novel drug combinations

Author： Illarramendi Ximena   de Oliveira Maria Leide Wand del Rey   Sales Anna Maria   da Costa Nery José Augusto   Sarno Euzenir Nunes  

Publisher： Future Science

ISSN： 2041-6792

Source： Clinical Investigation, Vol.3, Iss.7, 2013-07, pp. : 617-635

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sugammadex, a Promising Reversal Drug. A Review of Clinical Trials

By  

Reviews on Recent Clinical Trials, Vol. 6, Iss. 3, 2011-09 ,pp. : 250-255

Bentham Science Publishers

Access to resources Recommend Favorite

Novel outcome measures for clinical trials in cystic fibrosis

By  

PEDIATRIC PULMONOLOGY, Vol. 50, Iss. 3, 2015-03 ,pp. : 302-315

John Wiley & Sons Inc

Access to resources Recommend Favorite

Considerations in the design of clinical trials for pediatric acute lymphoblastic leukemia

By Devidas Meenakshi   Anderson James R  

Clinical Investigation, Vol. 3, Iss. 9, 2013-09 ,pp. : 849-858

Future Science

Access to resources Recommend Favorite

Population and target considerations for triple-negative breast cancer clinical trials

By Hyslop Terry   Michael Yvonne   Avery Tiffany   Rui Hallgeir  

Biomarkers in Medicine, Vol. 7, Iss. 1, 2013-02 ,pp. : 11-21

Future Medicine

Access to resources Recommend Favorite

Similarities and Differences in Design Considerations for Cell Therapy and Pharmacologic Cardiovascular Clinical Trials

By  

Cardiology, Vol. 110, Iss. 2, 2007-10 ,pp. : 73-80

Karger

Access to resources Recommend Favorite